?Global Compounding Pharmacies

Compounding Pharmacies Comprehensive Study by Type (Oral Medication (Capsules, Tablets, Suspensions, Lozenges, and Others), Topical Medication (Creams, Gels, Ointments, and Others), Mouthwashes, Suppositories), Application (Medication for Adults, Medication for Veterinary, Medication for Children, Medication for Geriatric), Distribution Channel (Compounding Pharmacies, Traditional Stores), Compounding (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA)), Sterility (Sterile, Non-sterile), Therapeutic Area (Pain Management, Hormone Replacement Therapy, Dermatological Applications, Others) Players and Region - Global Market Outlook to 2030

Compounding Pharmacies Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 5.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Compounding Pharmacies Market Scope
Compounding pharmacies are pharmacies that create drugs tailored to the requirements of individual patients by combining, altering or mixing active pharmaceutical ingredients of drugs. It is working on introducing new formulations effective in treating numerous illnesses. It is prepared under prescription from physicians. Compounding includes mixture of two or more drug ingredients in diverse proportions. Rise in the Hormone Replacement Therapy will help to boost global compounding pharmacies market.

According to AMA, the Global Compounding Pharmacies market is expected to see growth rate of 5.1%

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Compounding Pharmacies market throughout the predicted period.

AmerisourceBergen (United States), Rx3 Pharmacy (United States), Agbi’s Sterile Compounding Pharmacy LLC (United States), B. Braun Medical Inc. (United States), Cantrell Drug Company, Inc. (United States), Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd. (India), Village Sterile Compounding Pharmacy (United States), Imprimis Pharmaceuticals, Inc. (United States), Institutional Pharmacies Of Louisiana LLC (United States), Lorraine's Pharmacy (Canada) and Fresenius Kabi AG (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are McGuff Sterile Compounding Pharmacy Services, Inc. (United States), Panaceutics Inc. (United States), Pencol Compounding Pharmacy (United States), Fagron (Netherlands), ITC Compounding Pharmacy (United States), SCA Pharmaceuticals (United States) and Wedgewood Pharmacy (United States).

Segmentation Overview
The study have segmented the market of Global Compounding Pharmacies market by Type (Oral Medication [Capsules, Tablets, Suspensions, Lozenges, and Others], Topical Medication [Creams, Gels, Ointments, and Others], Mouthwashes and Suppositories), by Application (Medication for Adults, Medication for Veterinary, Medication for Children and Medication for Geriatric) and Region with country level break-up.

On the basis of geography, the market of Compounding Pharmacies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.

Influencing Trend:
Rise in the Hormone Replacement Therapy and Increase in the Number of Dispensed Prescriptions

Market Growth Drivers:
Increasing Pharmaceuticals and Healthcare Speeding’s and Growing Popularity of Compounded Drugs

Challenges:
Strengthen Government Regulations

Restraints:
High Price of Equipment Required For Compounding Medicine and Lack of Trained Workforce

Opportunities:
Innovation in Sub-Therapeutic Areas Including Bio-Identical Hormone Replacement Therapy and Huge Demand for Anti-Ageing Products

Market Leaders and their Expansionary Development Strategies
On 3rd January 2018, AmerisourceBergen Corp. a Wholesale pharmaceutical distribution and services company has acquired H.D. Smith. The deal is established for 815 million dollars.
On 10th December 2018, B. Braun Medical Inc. has installed innovative macro and micro APEX® Compounding System at Texas Children’s Hospital in Houston, Texas. It is designed for facilities that need in-house compounding capabilities and incorporates a large user interface, 26-lead preassembled transfer sets, and dual-drive filling technology with automated delivery as low as 0.2 mL.


Key Target Audience
Compounding Pharmacies Providers, Pharmaceutical Companies, Government Regularity Bodies, Government and Private Research/Consultancy Firms, Consulting Firms and Others

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • Oral Medication [Capsules, Tablets, Suspensions, Lozenges, and Others]
  • Topical Medication [Creams, Gels, Ointments, and Others]
  • Mouthwashes
  • Suppositories
By Application
  • Medication for Adults
  • Medication for Veterinary
  • Medication for Children
  • Medication for Geriatric
By Distribution Channel
  • Compounding Pharmacies
  • Traditional Stores

By Compounding
  • Pharmaceutical Ingredient Alteration [PIA]
  • Currently Unavailable Pharmaceutical Manufacturing [CUPM]
  • Pharmaceutical Dosage Alteration [PDA]

By Sterility
  • Sterile
  • Non-sterile

By Therapeutic Area
  • Pain Management
  • Hormone Replacement Therapy
  • Dermatological Applications
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Pharmaceuticals and Healthcare Speeding’s
      • 3.2.2. Growing Popularity of Compounded Drugs
    • 3.3. Market Challenges
      • 3.3.1. Strengthen Government Regulations
    • 3.4. Market Trends
      • 3.4.1. Rise in the Hormone Replacement Therapy
      • 3.4.2. Increase in the Number of Dispensed Prescriptions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Compounding Pharmacies, by Type, Application, Distribution Channel, Compounding, Sterility, Therapeutic Area and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Compounding Pharmacies (Value)
      • 5.2.1. Global Compounding Pharmacies by: Type (Value)
        • 5.2.1.1. Oral Medication [Capsules, Tablets, Suspensions, Lozenges, and Others]
        • 5.2.1.2. Topical Medication [Creams, Gels, Ointments, and Others]
        • 5.2.1.3. Mouthwashes
        • 5.2.1.4. Suppositories
      • 5.2.2. Global Compounding Pharmacies by: Application (Value)
        • 5.2.2.1. Medication for Adults
        • 5.2.2.2. Medication for Veterinary
        • 5.2.2.3. Medication for Children
        • 5.2.2.4. Medication for Geriatric
      • 5.2.3. Global Compounding Pharmacies by: Distribution Channel (Value)
        • 5.2.3.1. Compounding Pharmacies
        • 5.2.3.2. Traditional Stores
      • 5.2.4. Global Compounding Pharmacies by: Compounding (Value)
        • 5.2.4.1. Pharmaceutical Ingredient Alteration [PIA]
        • 5.2.4.2. Currently Unavailable Pharmaceutical Manufacturing [CUPM]
        • 5.2.4.3. Pharmaceutical Dosage Alteration [PDA]
      • 5.2.5. Global Compounding Pharmacies by: Sterility (Value)
        • 5.2.5.1. Sterile
        • 5.2.5.2. Non-sterile
      • 5.2.6. Global Compounding Pharmacies by: Therapeutic Area (Value)
        • 5.2.6.1. Pain Management
        • 5.2.6.2. Hormone Replacement Therapy
        • 5.2.6.3. Dermatological Applications
        • 5.2.6.4. Others
      • 5.2.7. Global Compounding Pharmacies Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
    • 5.3. Global Compounding Pharmacies (Price)
      • 5.3.1. Global Compounding Pharmacies by: Type (Price)
  • 6. Compounding Pharmacies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AmerisourceBergen (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Rx3 Pharmacy (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agbi’s Sterile Compounding Pharmacy LLC (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun Medical Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cantrell Drug Company, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd. (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Village Sterile Compounding Pharmacy (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Imprimis Pharmaceuticals, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Institutional Pharmacies Of Louisiana LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Lorraine's Pharmacy (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Fresenius Kabi AG (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Compounding Pharmacies Sale, by Type, Application, Distribution Channel, Compounding, Sterility, Therapeutic Area and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Compounding Pharmacies (Value)
      • 7.2.1. Global Compounding Pharmacies by: Type (Value)
        • 7.2.1.1. Oral Medication [Capsules, Tablets, Suspensions, Lozenges, and Others]
        • 7.2.1.2. Topical Medication [Creams, Gels, Ointments, and Others]
        • 7.2.1.3. Mouthwashes
        • 7.2.1.4. Suppositories
      • 7.2.2. Global Compounding Pharmacies by: Application (Value)
        • 7.2.2.1. Medication for Adults
        • 7.2.2.2. Medication for Veterinary
        • 7.2.2.3. Medication for Children
        • 7.2.2.4. Medication for Geriatric
      • 7.2.3. Global Compounding Pharmacies by: Distribution Channel (Value)
        • 7.2.3.1. Compounding Pharmacies
        • 7.2.3.2. Traditional Stores
      • 7.2.4. Global Compounding Pharmacies by: Compounding (Value)
        • 7.2.4.1. Pharmaceutical Ingredient Alteration [PIA]
        • 7.2.4.2. Currently Unavailable Pharmaceutical Manufacturing [CUPM]
        • 7.2.4.3. Pharmaceutical Dosage Alteration [PDA]
      • 7.2.5. Global Compounding Pharmacies by: Sterility (Value)
        • 7.2.5.1. Sterile
        • 7.2.5.2. Non-sterile
      • 7.2.6. Global Compounding Pharmacies by: Therapeutic Area (Value)
        • 7.2.6.1. Pain Management
        • 7.2.6.2. Hormone Replacement Therapy
        • 7.2.6.3. Dermatological Applications
        • 7.2.6.4. Others
      • 7.2.7. Global Compounding Pharmacies Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
    • 7.3. Global Compounding Pharmacies (Price)
      • 7.3.1. Global Compounding Pharmacies by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Compounding Pharmacies: by Type(USD Million)
  • Table 2. Compounding Pharmacies Oral Medication [Capsules, Tablets, Suspensions, Lozenges, and Others] , by Region USD Million (2018-2023)
  • Table 3. Compounding Pharmacies Topical Medication [Creams, Gels, Ointments, and Others] , by Region USD Million (2018-2023)
  • Table 4. Compounding Pharmacies Mouthwashes , by Region USD Million (2018-2023)
  • Table 5. Compounding Pharmacies Suppositories , by Region USD Million (2018-2023)
  • Table 6. Compounding Pharmacies: by Application(USD Million)
  • Table 7. Compounding Pharmacies Medication for Adults , by Region USD Million (2018-2023)
  • Table 8. Compounding Pharmacies Medication for Veterinary , by Region USD Million (2018-2023)
  • Table 9. Compounding Pharmacies Medication for Children , by Region USD Million (2018-2023)
  • Table 10. Compounding Pharmacies Medication for Geriatric , by Region USD Million (2018-2023)
  • Table 11. Compounding Pharmacies: by Distribution Channel(USD Million)
  • Table 12. Compounding Pharmacies Compounding Pharmacies , by Region USD Million (2018-2023)
  • Table 13. Compounding Pharmacies Traditional Stores , by Region USD Million (2018-2023)
  • Table 14. Compounding Pharmacies: by Compounding(USD Million)
  • Table 15. Compounding Pharmacies Pharmaceutical Ingredient Alteration [PIA] , by Region USD Million (2018-2023)
  • Table 16. Compounding Pharmacies Currently Unavailable Pharmaceutical Manufacturing [CUPM] , by Region USD Million (2018-2023)
  • Table 17. Compounding Pharmacies Pharmaceutical Dosage Alteration [PDA] , by Region USD Million (2018-2023)
  • Table 18. Compounding Pharmacies: by Sterility(USD Million)
  • Table 19. Compounding Pharmacies Sterile , by Region USD Million (2018-2023)
  • Table 20. Compounding Pharmacies Non-sterile , by Region USD Million (2018-2023)
  • Table 21. Compounding Pharmacies: by Therapeutic Area(USD Million)
  • Table 22. Compounding Pharmacies Pain Management , by Region USD Million (2018-2023)
  • Table 23. Compounding Pharmacies Hormone Replacement Therapy , by Region USD Million (2018-2023)
  • Table 24. Compounding Pharmacies Dermatological Applications , by Region USD Million (2018-2023)
  • Table 25. Compounding Pharmacies Others , by Region USD Million (2018-2023)
  • Table 26. South America Compounding Pharmacies, by Country USD Million (2018-2023)
  • Table 27. South America Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 28. South America Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 29. South America Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 30. South America Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 31. South America Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 32. South America Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 33. Brazil Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 34. Brazil Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 35. Brazil Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 36. Brazil Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 37. Brazil Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 38. Brazil Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 39. Argentina Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 40. Argentina Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 41. Argentina Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 42. Argentina Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 43. Argentina Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 44. Argentina Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 45. Rest of South America Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 46. Rest of South America Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 47. Rest of South America Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 48. Rest of South America Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 49. Rest of South America Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 50. Rest of South America Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 51. Asia Pacific Compounding Pharmacies, by Country USD Million (2018-2023)
  • Table 52. Asia Pacific Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 53. Asia Pacific Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 54. Asia Pacific Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 55. Asia Pacific Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 56. Asia Pacific Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 57. Asia Pacific Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 58. China Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 59. China Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 60. China Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 61. China Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 62. China Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 63. China Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 64. Japan Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 65. Japan Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 66. Japan Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 67. Japan Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 68. Japan Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 69. Japan Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 70. India Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 71. India Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 72. India Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 73. India Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 74. India Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 75. India Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 76. South Korea Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 77. South Korea Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 78. South Korea Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 79. South Korea Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 80. South Korea Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 81. South Korea Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 82. Taiwan Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 83. Taiwan Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 84. Taiwan Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 85. Taiwan Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 86. Taiwan Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 87. Taiwan Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 88. Australia Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 89. Australia Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 90. Australia Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 91. Australia Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 92. Australia Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 93. Australia Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 94. Rest of Asia-Pacific Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 95. Rest of Asia-Pacific Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 96. Rest of Asia-Pacific Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 97. Rest of Asia-Pacific Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 98. Rest of Asia-Pacific Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 99. Rest of Asia-Pacific Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 100. Europe Compounding Pharmacies, by Country USD Million (2018-2023)
  • Table 101. Europe Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 102. Europe Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 103. Europe Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 104. Europe Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 105. Europe Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 106. Europe Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 107. Germany Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 108. Germany Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 109. Germany Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 110. Germany Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 111. Germany Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 112. Germany Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 113. France Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 114. France Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 115. France Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 116. France Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 117. France Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 118. France Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 119. Italy Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 120. Italy Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 121. Italy Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 122. Italy Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 123. Italy Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 124. Italy Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 125. United Kingdom Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 126. United Kingdom Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 127. United Kingdom Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 128. United Kingdom Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 129. United Kingdom Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 130. United Kingdom Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 131. Netherlands Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 132. Netherlands Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 133. Netherlands Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 134. Netherlands Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 135. Netherlands Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 136. Netherlands Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 137. Rest of Europe Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 138. Rest of Europe Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 139. Rest of Europe Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 140. Rest of Europe Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 141. Rest of Europe Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 142. Rest of Europe Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 143. MEA Compounding Pharmacies, by Country USD Million (2018-2023)
  • Table 144. MEA Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 145. MEA Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 146. MEA Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 147. MEA Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 148. MEA Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 149. MEA Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 150. Middle East Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 151. Middle East Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 152. Middle East Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 153. Middle East Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 154. Middle East Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 155. Middle East Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 156. Africa Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 157. Africa Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 158. Africa Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 159. Africa Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 160. Africa Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 161. Africa Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 162. North America Compounding Pharmacies, by Country USD Million (2018-2023)
  • Table 163. North America Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 164. North America Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 165. North America Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 166. North America Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 167. North America Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 168. North America Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 169. United States Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 170. United States Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 171. United States Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 172. United States Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 173. United States Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 174. United States Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 175. Canada Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 176. Canada Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 177. Canada Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 178. Canada Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 179. Canada Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 180. Canada Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 181. Mexico Compounding Pharmacies, by Type USD Million (2018-2023)
  • Table 182. Mexico Compounding Pharmacies, by Application USD Million (2018-2023)
  • Table 183. Mexico Compounding Pharmacies, by Distribution Channel USD Million (2018-2023)
  • Table 184. Mexico Compounding Pharmacies, by Compounding USD Million (2018-2023)
  • Table 185. Mexico Compounding Pharmacies, by Sterility USD Million (2018-2023)
  • Table 186. Mexico Compounding Pharmacies, by Therapeutic Area USD Million (2018-2023)
  • Table 187. Compounding Pharmacies: by Type(USD/Units)
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Compounding Pharmacies: by Type(USD Million)
  • Table 200. Compounding Pharmacies Oral Medication [Capsules, Tablets, Suspensions, Lozenges, and Others] , by Region USD Million (2025-2030)
  • Table 201. Compounding Pharmacies Topical Medication [Creams, Gels, Ointments, and Others] , by Region USD Million (2025-2030)
  • Table 202. Compounding Pharmacies Mouthwashes , by Region USD Million (2025-2030)
  • Table 203. Compounding Pharmacies Suppositories , by Region USD Million (2025-2030)
  • Table 204. Compounding Pharmacies: by Application(USD Million)
  • Table 205. Compounding Pharmacies Medication for Adults , by Region USD Million (2025-2030)
  • Table 206. Compounding Pharmacies Medication for Veterinary , by Region USD Million (2025-2030)
  • Table 207. Compounding Pharmacies Medication for Children , by Region USD Million (2025-2030)
  • Table 208. Compounding Pharmacies Medication for Geriatric , by Region USD Million (2025-2030)
  • Table 209. Compounding Pharmacies: by Distribution Channel(USD Million)
  • Table 210. Compounding Pharmacies Compounding Pharmacies , by Region USD Million (2025-2030)
  • Table 211. Compounding Pharmacies Traditional Stores , by Region USD Million (2025-2030)
  • Table 212. Compounding Pharmacies: by Compounding(USD Million)
  • Table 213. Compounding Pharmacies Pharmaceutical Ingredient Alteration [PIA] , by Region USD Million (2025-2030)
  • Table 214. Compounding Pharmacies Currently Unavailable Pharmaceutical Manufacturing [CUPM] , by Region USD Million (2025-2030)
  • Table 215. Compounding Pharmacies Pharmaceutical Dosage Alteration [PDA] , by Region USD Million (2025-2030)
  • Table 216. Compounding Pharmacies: by Sterility(USD Million)
  • Table 217. Compounding Pharmacies Sterile , by Region USD Million (2025-2030)
  • Table 218. Compounding Pharmacies Non-sterile , by Region USD Million (2025-2030)
  • Table 219. Compounding Pharmacies: by Therapeutic Area(USD Million)
  • Table 220. Compounding Pharmacies Pain Management , by Region USD Million (2025-2030)
  • Table 221. Compounding Pharmacies Hormone Replacement Therapy , by Region USD Million (2025-2030)
  • Table 222. Compounding Pharmacies Dermatological Applications , by Region USD Million (2025-2030)
  • Table 223. Compounding Pharmacies Others , by Region USD Million (2025-2030)
  • Table 224. South America Compounding Pharmacies, by Country USD Million (2025-2030)
  • Table 225. South America Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 226. South America Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 227. South America Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 228. South America Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 229. South America Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 230. South America Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 231. Brazil Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 232. Brazil Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 233. Brazil Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 234. Brazil Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 235. Brazil Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 236. Brazil Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 237. Argentina Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 238. Argentina Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 239. Argentina Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 240. Argentina Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 241. Argentina Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 242. Argentina Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 243. Rest of South America Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 244. Rest of South America Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 245. Rest of South America Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 246. Rest of South America Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 247. Rest of South America Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 248. Rest of South America Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 249. Asia Pacific Compounding Pharmacies, by Country USD Million (2025-2030)
  • Table 250. Asia Pacific Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 251. Asia Pacific Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 252. Asia Pacific Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 253. Asia Pacific Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 254. Asia Pacific Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 255. Asia Pacific Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 256. China Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 257. China Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 258. China Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 259. China Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 260. China Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 261. China Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 262. Japan Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 263. Japan Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 264. Japan Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 265. Japan Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 266. Japan Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 267. Japan Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 268. India Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 269. India Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 270. India Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 271. India Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 272. India Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 273. India Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 274. South Korea Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 275. South Korea Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 276. South Korea Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 277. South Korea Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 278. South Korea Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 279. South Korea Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 280. Taiwan Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 281. Taiwan Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 282. Taiwan Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 283. Taiwan Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 284. Taiwan Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 285. Taiwan Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 286. Australia Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 287. Australia Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 288. Australia Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 289. Australia Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 290. Australia Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 291. Australia Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 292. Rest of Asia-Pacific Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 293. Rest of Asia-Pacific Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 294. Rest of Asia-Pacific Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 295. Rest of Asia-Pacific Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 296. Rest of Asia-Pacific Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 297. Rest of Asia-Pacific Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 298. Europe Compounding Pharmacies, by Country USD Million (2025-2030)
  • Table 299. Europe Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 300. Europe Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 301. Europe Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 302. Europe Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 303. Europe Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 304. Europe Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 305. Germany Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 306. Germany Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 307. Germany Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 308. Germany Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 309. Germany Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 310. Germany Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 311. France Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 312. France Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 313. France Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 314. France Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 315. France Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 316. France Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 317. Italy Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 318. Italy Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 319. Italy Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 320. Italy Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 321. Italy Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 322. Italy Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 323. United Kingdom Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 324. United Kingdom Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 325. United Kingdom Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 326. United Kingdom Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 327. United Kingdom Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 328. United Kingdom Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 329. Netherlands Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 330. Netherlands Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 331. Netherlands Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 332. Netherlands Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 333. Netherlands Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 334. Netherlands Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 335. Rest of Europe Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 336. Rest of Europe Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 337. Rest of Europe Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 338. Rest of Europe Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 339. Rest of Europe Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 340. Rest of Europe Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 341. MEA Compounding Pharmacies, by Country USD Million (2025-2030)
  • Table 342. MEA Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 343. MEA Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 344. MEA Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 345. MEA Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 346. MEA Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 347. MEA Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 348. Middle East Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 349. Middle East Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 350. Middle East Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 351. Middle East Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 352. Middle East Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 353. Middle East Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 354. Africa Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 355. Africa Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 356. Africa Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 357. Africa Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 358. Africa Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 359. Africa Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 360. North America Compounding Pharmacies, by Country USD Million (2025-2030)
  • Table 361. North America Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 362. North America Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 363. North America Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 364. North America Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 365. North America Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 366. North America Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 367. United States Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 368. United States Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 369. United States Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 370. United States Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 371. United States Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 372. United States Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 373. Canada Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 374. Canada Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 375. Canada Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 376. Canada Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 377. Canada Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 378. Canada Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 379. Mexico Compounding Pharmacies, by Type USD Million (2025-2030)
  • Table 380. Mexico Compounding Pharmacies, by Application USD Million (2025-2030)
  • Table 381. Mexico Compounding Pharmacies, by Distribution Channel USD Million (2025-2030)
  • Table 382. Mexico Compounding Pharmacies, by Compounding USD Million (2025-2030)
  • Table 383. Mexico Compounding Pharmacies, by Sterility USD Million (2025-2030)
  • Table 384. Mexico Compounding Pharmacies, by Therapeutic Area USD Million (2025-2030)
  • Table 385. Compounding Pharmacies: by Type(USD/Units)
  • Table 386. Research Programs/Design for This Report
  • Table 387. Key Data Information from Secondary Sources
  • Table 388. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Compounding Pharmacies: by Type USD Million (2018-2023)
  • Figure 5. Global Compounding Pharmacies: by Application USD Million (2018-2023)
  • Figure 6. Global Compounding Pharmacies: by Distribution Channel USD Million (2018-2023)
  • Figure 7. Global Compounding Pharmacies: by Compounding USD Million (2018-2023)
  • Figure 8. Global Compounding Pharmacies: by Sterility USD Million (2018-2023)
  • Figure 9. Global Compounding Pharmacies: by Therapeutic Area USD Million (2018-2023)
  • Figure 10. South America Compounding Pharmacies Share (%), by Country
  • Figure 11. Asia Pacific Compounding Pharmacies Share (%), by Country
  • Figure 12. Europe Compounding Pharmacies Share (%), by Country
  • Figure 13. MEA Compounding Pharmacies Share (%), by Country
  • Figure 14. North America Compounding Pharmacies Share (%), by Country
  • Figure 15. Global Compounding Pharmacies: by Type USD/Units (2018-2023)
  • Figure 16. Global Compounding Pharmacies share by Players 2023 (%)
  • Figure 17. Global Compounding Pharmacies share by Players (Top 3) 2023(%)
  • Figure 18. Global Compounding Pharmacies share by Players (Top 5) 2023(%)
  • Figure 19. BCG Matrix for key Companies
  • Figure 20. AmerisourceBergen (United States) Revenue, Net Income and Gross profit
  • Figure 21. AmerisourceBergen (United States) Revenue: by Geography 2023
  • Figure 22. Rx3 Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 23. Rx3 Pharmacy (United States) Revenue: by Geography 2023
  • Figure 24. Agbi’s Sterile Compounding Pharmacy LLC (United States) Revenue, Net Income and Gross profit
  • Figure 25. Agbi’s Sterile Compounding Pharmacy LLC (United States) Revenue: by Geography 2023
  • Figure 26. B. Braun Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. B. Braun Medical Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Cantrell Drug Company, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Cantrell Drug Company, Inc. (United States) Revenue: by Geography 2023
  • Figure 30. Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 31. Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 32. Village Sterile Compounding Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 33. Village Sterile Compounding Pharmacy (United States) Revenue: by Geography 2023
  • Figure 34. Imprimis Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Imprimis Pharmaceuticals, Inc. (United States) Revenue: by Geography 2023
  • Figure 36. Institutional Pharmacies Of Louisiana LLC (United States) Revenue, Net Income and Gross profit
  • Figure 37. Institutional Pharmacies Of Louisiana LLC (United States) Revenue: by Geography 2023
  • Figure 38. Lorraine's Pharmacy (Canada) Revenue, Net Income and Gross profit
  • Figure 39. Lorraine's Pharmacy (Canada) Revenue: by Geography 2023
  • Figure 40. Fresenius Kabi AG (Germany) Revenue, Net Income and Gross profit
  • Figure 41. Fresenius Kabi AG (Germany) Revenue: by Geography 2023
  • Figure 42. Global Compounding Pharmacies: by Type USD Million (2025-2030)
  • Figure 43. Global Compounding Pharmacies: by Application USD Million (2025-2030)
  • Figure 44. Global Compounding Pharmacies: by Distribution Channel USD Million (2025-2030)
  • Figure 45. Global Compounding Pharmacies: by Compounding USD Million (2025-2030)
  • Figure 46. Global Compounding Pharmacies: by Sterility USD Million (2025-2030)
  • Figure 47. Global Compounding Pharmacies: by Therapeutic Area USD Million (2025-2030)
  • Figure 48. South America Compounding Pharmacies Share (%), by Country
  • Figure 49. Asia Pacific Compounding Pharmacies Share (%), by Country
  • Figure 50. Europe Compounding Pharmacies Share (%), by Country
  • Figure 51. MEA Compounding Pharmacies Share (%), by Country
  • Figure 52. North America Compounding Pharmacies Share (%), by Country
  • Figure 53. Global Compounding Pharmacies: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • AmerisourceBergen (United States)
  • Rx3 Pharmacy (United States)
  • Agbi’s Sterile Compounding Pharmacy LLC (United States)
  • B. Braun Medical Inc. (United States)
  • Cantrell Drug Company, Inc. (United States)
  • Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd. (India)
  • Village Sterile Compounding Pharmacy (United States)
  • Imprimis Pharmaceuticals, Inc. (United States)
  • Institutional Pharmacies Of Louisiana LLC (United States)
  • Lorraine's Pharmacy (Canada)
  • Fresenius Kabi AG (Germany)
Additional players considered in the study are as follows:
McGuff Sterile Compounding Pharmacy Services, Inc. (United States) , Panaceutics Inc. (United States) , Pencol Compounding Pharmacy (United States) , Fagron (Netherlands) , ITC Compounding Pharmacy (United States) , SCA Pharmaceuticals (United States) , Wedgewood Pharmacy (United States)
Select User Access Type

Key Highlights of Report


Nov 2024 216 Pages 53 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
?Global Compounding Pharmacies Quantitative research analysis
?Global Compounding Pharmacies Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Compounding Pharmacies study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Compounding Pharmacies Market is gaining popularity and expected to see strong valuation by 2030 .
According to AMA, the Global Compounding Pharmacies market is expected to see growth rate of xx%.
The Compounding Pharmacies market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About ?Global Compounding Pharmacies Report?

Have a Query? Click Here

Other Related Reports

Vitamin B3 Comprehensive Study by Type (Pharmaceutical Grade, Feed Grade), Application (Feed Additives, Food and Drinks Industry, Pharmaceutical Industry, Daily Chemicals) Players and Region - Global...
$ 3500
Pharmaceutical & Biotechnology Environmental Monitoring Comprehensive Study by Type (Monitoring Equipment (Particle Counters, Air Samplers, Temperature/ Humidity Monitors, Microbial Identification Sy...
$ 3350
Allergy Medicine Comprehensive Study by Type (Tablet, Liquid), Allergy (Drug Allergy, Food Allergy, Skin Allergy, Insect Allergy, Latex Allergy, Others), Symptoms (Hives, Fever) Players and Region -...
$ 3500
Metronidazole Comprehensive Study by Type (Metronidazole Tablets, Metronidazole Capsule, Metronidazole Injection, Others), Application (Anaerobic Bacterial Infections, Sexually Transmitted Disease, B...
$ 3750
Botox Comprehensive Study by Type (Botulinum Toxin Type A, Botulinum Toxin Type B), Application (Aesthetic Use, Therapeutics Use), End User (Clinics) Players and Region - Global Market Outlook to 202...
$ 3500
Ampoules Packaging Comprehensive Study by Type (Polyvinyl Chloride, Polyethylene Terephthalate, High Impact Polystyrene), Application (Pharmaceuticals, Personal Care, Chemical, Others), Category (Gla...
$ 3800